Related Experiment Video
Updated: Aug 23, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Pharmacotherapy of bipolar disorder in old age: review and recommendations
Robert C Young1, Laszlo Gyulai, Benoit H Mulsant
1Payne-Whitney, Westchester, and the Institute for Geriatric Psychiatry, Department of Psychiatry, Weill Medical College of Cornell University, 21 Bloomingdale Road, White Plains, New York 10605, USA. ryoung@med.cornell.edu
Abstract:
The authors reviewed the evidence-base for pharmacological treatment of mania and bipolar (BP) depression in late life. Treatment benefits and side effects may be modified by age-associated factors, such as neurocognitive impairments. Lithium and divalproex have most often been studied in elderly patients, and both may be efficacious in acute treatment of mania, but there are no controlled efficacy or effectiveness trials. The role of atypical antipsychotic agents remains to be clarified. Similarly, there are no systematic studies of the treatment of BP depression in elderly patients. The authors make suggestions for management and delineate priorities for research.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Mania and Antimanic Drugs: Overview
Drug Dosing: Geriatric Patients
Psychosis: Goals of Pharmacotherapy
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption